CHANGING EPIDEMIOLOGY OF THYROID CANCER

改变甲状腺癌的流行病学

基本信息

  • 批准号:
    2094891
  • 负责人:
  • 金额:
    $ 26.57万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1991
  • 资助国家:
    美国
  • 起止时间:
    1991-08-23 至 1996-05-31
  • 项目状态:
    已结题

项目摘要

While rates of thyroid cancer among men have declined during the 1970s and 1980s in western Washington, rates among women have increased. The increase in incidence is particularly marked for women aged 35-54, in whom rates have nearly doubled from 1974-1987. Exposure to childhood irradiation of the head and neck (the principal established risk factor for thyroid cancer) seems unlikely to fully account for these observations, given the declining prevalence of this exposure among women in this age group. Previous studies suggest that hormonal factors, such as use of exogenous estrogens, parity and hormonal abnormalities associated with miscarriage and infertility may increase risk of thyroid cancer. However, these earlier studies may have considerably underestimated risk associated with oral contraceptive use due to inadequate opportunity for exposure, inadequate years of elapsed latent period, or greater prevalence of radiation-induced cancers. We propose a population-based case-control study of thyroid cancer among women in three counties of western Washington to test the hypothesis that oral contraceptive use, particularly that occurring early in life or for long time periods, may increase risk of thyroid cancer. All white female residents of King, Pierce, and Snohomish Counties aged 18-64 years and diagnosed with incident thyroid cancer of the follicular epithelium from January 1, 1988 through June 30, 1995 will be identified and invited to participate in the study. Cases will be identified through the Cancer Surveillance System (CSS), a population-based tumor registry that has served the area since 1974. Controls will be selected-by random digit dialing and will be frequency matched to cases on age (by five-year intervals) and county of residence. Cases and controls will be interviewed in person regarding their use of oral contraceptives and other exogenous estrogens, as well as reproductive and menstrual history, history of infertility and other known or suspected risk factors for thyroid cancer.
虽然男性甲状腺癌的发病率在20世纪70年代和70年代有所下降

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JANET R DALING其他文献

JANET R DALING的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JANET R DALING', 18)}}的其他基金

EPIDEMIOLOGY OF HPV-RELATED SCSC IN TRANSPLANT PATIENTS
移植患者中 HPV 相关 SCSC 的流行病学
  • 批准号:
    7300320
  • 财政年份:
    2007
  • 资助金额:
    $ 26.57万
  • 项目类别:
Tamoxifen & Second Breast Cancer: Epidemiology/Pathology
他莫昔芬
  • 批准号:
    6756560
  • 财政年份:
    2003
  • 资助金额:
    $ 26.57万
  • 项目类别:
Tamoxifen & Second Breast Cancer: Epidemiology/Pathology
他莫昔芬
  • 批准号:
    6619122
  • 财政年份:
    2003
  • 资助金额:
    $ 26.57万
  • 项目类别:
ANOGENITAL CANCER--EPIDEMIOLOGY/BIOCHEMISTRY/IMMUNOLOGY
肛门生殖器癌--流行病学/生物化学/免疫学
  • 批准号:
    6580339
  • 财政年份:
    2002
  • 资助金额:
    $ 26.57万
  • 项目类别:
HRT USE AND RISK OF LOBULAR AND DUCTAL BREAST CANCER
HRT 的使用以及小叶和导管乳腺癌的风险
  • 批准号:
    6377823
  • 财政年份:
    2000
  • 资助金额:
    $ 26.57万
  • 项目类别:
HRT USE AND RISK OF LOBULAR AND DUCTAL BREAST CANCER
HRT 的使用以及小叶和导管乳腺癌的风险
  • 批准号:
    6556281
  • 财政年份:
    2000
  • 资助金额:
    $ 26.57万
  • 项目类别:
HRT USE AND RISK OF LOBULAR AND DUCTAL BREAST CANCER
HRT 的使用以及小叶和导管乳腺癌的风险
  • 批准号:
    6603759
  • 财政年份:
    2000
  • 资助金额:
    $ 26.57万
  • 项目类别:
HRT USE AND RISK OF LOBULAR AND DUCTAL BREAST CANCER
HRT 的使用以及小叶和导管乳腺癌的风险
  • 批准号:
    6765901
  • 财政年份:
    2000
  • 资助金额:
    $ 26.57万
  • 项目类别:
HRT USE AND RISK OF LOBULAR AND DUCTAL BREAST CANCER
HRT 的使用以及小叶和导管乳腺癌的风险
  • 批准号:
    6091297
  • 财政年份:
    2000
  • 资助金额:
    $ 26.57万
  • 项目类别:
HRT USE AND RISK OF LOBULAR AND DUCTAL BREAST CANCER
HRT 的使用以及小叶和导管乳腺癌的风险
  • 批准号:
    6514470
  • 财政年份:
    2000
  • 资助金额:
    $ 26.57万
  • 项目类别:

相似海外基金

Urinary Phthalate Biomarker Concentrations and Breast and Prostate Cancer Risk in a National Cohort of Adults in Canada
加拿大全国成人队列中尿液邻苯二甲酸盐生物标志物浓度与乳腺癌和前列腺癌风险
  • 批准号:
    494953
  • 财政年份:
    2023
  • 资助金额:
    $ 26.57万
  • 项目类别:
    Operating Grants
Prospective metabolomics investigation of gastric cancer risk in African Americans and European Whites with a low socioeconomic status
社会经济地位较低的非裔美国人和欧洲白人胃癌风险的前瞻性代谢组学调查
  • 批准号:
    10912190
  • 财政年份:
    2023
  • 资助金额:
    $ 26.57万
  • 项目类别:
Deep Learning Image Analysis Algorithms to Improve Oral Cancer Risk Assessment for Oral Potentially Malignant Disorders
深度学习图像分析算法可改善口腔潜在恶性疾病的口腔癌风险评估
  • 批准号:
    10805177
  • 财政年份:
    2023
  • 资助金额:
    $ 26.57万
  • 项目类别:
Clinical breast cancer risk prediction models for women with a high-risk benign breast diagnosis
高风险良性乳腺诊断女性的临床乳腺癌风险预测模型
  • 批准号:
    10719777
  • 财政年份:
    2023
  • 资助金额:
    $ 26.57万
  • 项目类别:
Developing diagnostics of patient-specific cancer risk and early-stage tumorigenesis
开发患者特异性癌症风险和早期肿瘤发生的诊断方法
  • 批准号:
    478999
  • 财政年份:
    2023
  • 资助金额:
    $ 26.57万
  • 项目类别:
    Operating Grants
Environmental Metal Exposures and Breast Cancer Risk: A Prospective Study of Nationally Representative Canadian Data
环境金属暴露与乳腺癌风险:加拿大全国代表性数据的前瞻性研究
  • 批准号:
    495159
  • 财政年份:
    2023
  • 资助金额:
    $ 26.57万
  • 项目类别:
Mechanisms of tamoxifen-associated endometrial cancer risk
他莫昔芬相关子宫内膜癌风险的机制
  • 批准号:
    10650054
  • 财政年份:
    2023
  • 资助金额:
    $ 26.57万
  • 项目类别:
Gut microbiota-related mechanisms that impact colorectal cancer risk after bariatric surgery
影响减肥手术后结直肠癌风险的肠道微生物相关机制
  • 批准号:
    10733566
  • 财政年份:
    2023
  • 资助金额:
    $ 26.57万
  • 项目类别:
Obesity, body fat distribution, and breast cancer risk: is visceral fat the culprit after menopause?
肥胖、身体脂肪分布和乳腺癌风险:内脏脂肪是绝经后的罪魁祸首吗?
  • 批准号:
    10586626
  • 财政年份:
    2023
  • 资助金额:
    $ 26.57万
  • 项目类别:
Optimization of a personalized skin cancer risk intervention for at-risk young adults
针对高危年轻人的个性化皮肤癌风险干预措施的优化
  • 批准号:
    10582944
  • 财政年份:
    2023
  • 资助金额:
    $ 26.57万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了